youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
GERN:NASDAQ
Geron Corp
$0.89
arrow_downward
-5.47%(-0.052) 1D
$0.89
arrow_downward
-0.48% (-0.0043)bedtimeAfter hours
Closed: Oct 30, 3:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$0.93
High
$0.94
Low
$0.86
Mkt. cap
572.33M
Avg. vol.
11.47M
Volume
18.81M
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$0.93
High
$0.94
Low
$0.86
Mkt. cap
572.33M
Avg. vol.
11.47M
Volume
18.81M
52-wk high
$2.01
52-wk low
$0.84
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
The Pharma Letter
·
2 days ago
Geron shares fall after independent monitors halt Phase III myelofibrosis trial of imetelstat
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com